Pulmonary Cavitation As a Complication of Covid-19: Case Series and a Brief Review of the Literature Publisher



M Aghamohammadi MEHDI ; S Ghodrati S ; M Etemadi MILAD ; Ms Sehat Mohammad SOROUSH ; J Alizargar JAVAD
Source: Acta Microbiologica Hellenica (Switzerland) Published:2024

Abstract

The COVID-19 pandemic has led to an unprecedented surge in respiratory illness cases worldwide. Although uncommon, pulmonary cavitation has been reported as a potential complication of COVID-19. This case series report describes four cases of COVID-19 patients with lung cavities, highlighting the various causes and clinical manifestations of this complication, and a review of the literature on the presence of lung cavities in COVID-19 patients. In two cases, the cavities were most likely due to secondary bacterial superinfections, with one case being complicated by multi-drug-resistant bacteria. Another case developed cavities secondary to a fungal infection, while the third case was directly caused by SARS-CoV-2 invasion in the lungs. The presence of cavities with or without air-fluid level or pneumothorax in COVID-19 patients should be considered as a potential complication of this infection, especially in those with respiratory symptoms. Physicians should remain vigilant for the development of pulmonary cavitation in COVID-19 patients, particularly those receiving high doses of steroids. Additionally, spontaneous pneumothorax should be considered an alarming sign in COVID-19 patients. © 2025 Elsevier B.V., All rights reserved.